The Preston A. Wells Center for Brain Tumor Therapy team presented research findings and collaborated with brain tumor researchers from around the world at the 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology in Phoenix, Arizona on November 22-24, 2019.
The team presented talks, oral abstracts, posters, and E-talks. Dr. Duane Mitchell also served as Co-Chair of Education Day.
Presentations included:
- Advancing Immunotherapy for Brain Tumors (Duane Mitchell)
- Cellular immunotherapy to overcome temozolomide induced T cell exhaustion in glioblastoma (Aida Karachi & Maryam Rahman)
- Disruption of the CCR2 chemokine receptor pathway overcomes therapeutic resistance to PD-1 blockade in malignant glioma (Joseph Flores-Toro & Jeff Harrison)
- Immunotherapy for GBM. Should we move on? (Duane Mitchell)
- Increasing the trafficking of dendritic cells via CXC chemokine signaling pathway leads to improved anti-tumor efficacy of dendritic cell vaccines (Farhad Dastmalchi & Maryam Rahman)
- Mechanisms of immunological escape during adoptive cellular therapy in high grade glioma (Tyler Wildes & Catherine Flores)
- Metabolic interactions between treatment-resistant slow-cycling cells and the immune system in high-grade glioma (Loic Deleyrolle)
- RNA loaded lipid-nanoparticles function as customizable immunotherapeutic vehicles against malignant gliomas (Elias Sayour)
- RNA-nanoparticle vaccines are safe and immunologically active in clientowned canines with terminal gliomas (Elias Sayour)
- State of the field of immunotherapy for brain tumors (Duane Mitchell)
- The selective enrichment of T cells targeting unknown brain cancer antigens via trogocytosis (Ginger Moore)
More about the Preston A. Wells Center for Brain Tumor Therapy program.
